MiRNA-375 was downregulated in OSCC and progressive OLs compared to non-progressive lesions, suggesting its role as a tumour suppressor during oral carcinogenesis, probably through the regulation of the expression of Myc and insulin-like growth factor (IGF) oncogenes (12). The gene discussed is MYC; the disease is neoplasm.